Japan Lifeline Co., Ltd. (7575) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROE of 14.22%

Company has very low debt and has enough cash to service the debt requirements

Poor long term growth as Operating profit has grown by an annual rate 1.71% of over the last 5 years

Flat results in Jun 25

With ROE of 15.74%, it has a very attractive valuation with a 1.85 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 115,456 Million (Small Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.07

Return on Equity

16.10%

Price to Book

1.98

Revenue and Profits:

Net Sales:

14,616 Million

(Quarterly Results - Jun 2025)

Net Profit:

2,302 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.92%

6 Months

3.1%

1 Year

15.75%

2 Years

31.13%

3 Years

63.53%

4 Years

41.44%

5 Years

-5.27%

Japan Lifeline Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.81%

EBIT Growth (5y)

1.71%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.87

Tax Ratio

22.51%

Dividend Payout Ratio

40.33%

Pledged Shares

Institutional Holding

ROCE (avg)

22.47%

ROE (avg)

14.22%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.85

EV to EBIT

9.11

EV to EBITDA

7.79

EV to Capital Employed

1.97

EV to Sales

1.83

PEG Ratio

0.59

Dividend Yield

ROCE (Latest)

21.62%

ROE (Latest)

15.74%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.92% vs -6.93% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 2.49% vs -14.80% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,616.00",
          "val2": "13,799.00",
          "chgp": "5.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,677.00",
          "val2": "2,883.00",
          "chgp": "27.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.00",
          "val2": "9.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.00",
          "val2": "-58.00",
          "chgp": "94.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,302.00",
          "val2": "2,246.00",
          "chgp": "2.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "223.90%",
          "val2": "175.40%",
          "chgp": "4.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 10.17% vs -0.71% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 23.98% vs 9.06% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "56,610.00",
          "val2": "51,384.00",
          "chgp": "10.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14,617.00",
          "val2": "12,827.00",
          "chgp": "13.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "36.00",
          "val2": "26.00",
          "chgp": "38.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-335.00",
          "val2": "-660.00",
          "chgp": "49.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9,317.00",
          "val2": "7,515.00",
          "chgp": "23.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "221.20%",
          "val2": "214.80%",
          "chgp": "0.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

14,616.00

13,799.00

5.92%

Operating Profit (PBDIT) excl Other Income

3,677.00

2,883.00

27.54%

Interest

9.00

Exceptional Items

-3.00

-58.00

94.83%

Consolidate Net Profit

2,302.00

2,246.00

2.49%

Operating Profit Margin (Excl OI)

223.90%

175.40%

4.85%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.92% vs -6.93% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 2.49% vs -14.80% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

56,610.00

51,384.00

10.17%

Operating Profit (PBDIT) excl Other Income

14,617.00

12,827.00

13.95%

Interest

36.00

26.00

38.46%

Exceptional Items

-335.00

-660.00

49.24%

Consolidate Net Profit

9,317.00

7,515.00

23.98%

Operating Profit Margin (Excl OI)

221.20%

214.80%

0.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 10.17% vs -0.71% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 23.98% vs 9.06% in Mar 2024

All Annual Results

Company CV

About Japan Lifeline Co., Ltd.

Japan Lifeline Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available